Search    ENTER KEYWORD
MSDS Material Safety Data Sheet
CAS

N/A

File Name: bimsds_us_Disal_injection_msds.asp

DISAL (FUROSEMIDE) INJECTION NADA #: 131-538


Material Safety Data Sheet
DOT HCS Risk Phrases Protective Clothing

Not an HCS controlled material in USA.




Section 1: Product Identification and Uses
Common/Trade
DISAL (FUROSEMIDE) INJECTION NADA #:
name
CI# Not available
131-538

Synonyms Not available TSCA TSCA inventory:
No products found.
Chemical name Not applicable CAS# Not applicable
Chemical formula Not available Code MSDS ID#: P131-538
Chemical family Diuretic Molecular Not applicable
weight
Manufacturer Boehringer Ingelheim Vetmedica, Inc.
Supplier Boehringer Ingelheim Vetmedica, Inc. 2621 North Belt Hwy
2621 North Belt Hwy St. Joseph MO 64506-2002
St. Joseph MO 64506-2002 816-233-2571
Material uses An effective diuretic-saluretic for oral use in the treatment of edema (pulmonary congestion, ascites)
associated with cardiac insufficiency and acute noninflammatory tissue edema. Use only as directed on the
product label and package insert.
Section 2: Hazardous Ingredients
Name CAS# % by Weight TLV/PEL LC50 / LD 50
Not available
1) Furosemide: 4- 000054319 50 mg/mL Not available
chloro-N-furfuryl-5-
sulfamoylanthranilic
acid
2)Monoethanolamine. 000141435 5% 3 ppm TWA, 6 ppm
1720 mg/kg
STEL ACGIH and
OSHA

Section 3: First Aid Measures
Eye contact Flush eyes with plenty of water for at least 15 minutes, occasionally lifting thie upper and lower eyelids. Seek
medical attention if irritation persists.
Skin contact Wash contaminated skin with soap and water. Seek medical attention if irritation persists.
Hazardous skin
No additional information.
contact

Slight inhalation Allow the victim to rest in a well ventilated area. Apply artificial respiration if needed.
Hazardous inhalation No additional information.
Slight ingestion Not for human use. If swallowed seek medical assistance.
Hazardous ingestion Not available

Section 4: Physical Data
Liquid.
Physical state and
appearance
Odor Odorless
PH (1% soln/water) @8.6 Taste Not available
DISAL (FUROSEMIDE) INJECTION NADA #: 131-538
Odor threshold Not available Color Clear. Colorless
Volatility Not available
Melting/Sublimation point Not available
Boiling/Condensation point 212掳 F
Specific gravity (Water=1) 1.06
Vapor density Not available
Vapor pressure Not available
Water/oil dist. Coeff. Not available
Ionicity (surface active Not available
agent)

Critical temperature Not available
Instability temperature Not available
Conditions of instability Not additional remark.
Dispersion properties Not available
Solubility Miscible in water.

Section 5: Fire and Explosion Data
The product is: Not available
Auto-ignition Not available
temperature

Fire degradation Not available
products

Flash points Not available
Flammable limits Not available
Fire extinguishing
None. Product is > 90% water.
procedures

Flammability No specific information is available in our database regarding the flammability of this product in presence of
various materials.
Risks of explosion None. Product is > 90% water.

Page 2 of 4
DISAL (FUROSEMIDE) INJECTION NADA #: 131-538
Section 6: Reactivity Data
Stability The product is stable.
Hazardous decomp. The active ingredient, furosemide, and monoethanolamine, emits toxic fumes when heated to
products decomposition.
Degradability Not available
Product of Possibly hazardous short term degradation products are not likely. However, long term degradation products
degradation may arise.
Not available
Corrosivity No specific information is available in our database regarding the corrosivity of this product in the presence
of various materials.
Reactivity Oxidizing and reactive materials.


Section 7: Toxicological Properties
Routes of entry Ingestion. Inhalation. Skin contact.
TLV Not available
Toxicity for animals LD50: Not available
LC50: Not available
Environmental hazards Not available
Chronic effects on humans Carcinogenic Effects: Not carcinogenic
Mutagenic Effects: Not available
Teratogenic Effects: Not available
Developmental Toxicity: Not available. Hypersensitivity to this and sulfonamide-like drugs.

Acute effects on humans Ingestion may cause nausea, vomiting, diuresis, weakness



Section 8: Preventive Measures
Waste information Not a RCRA waste. Dispose of waste and containers in accordance with local, state and federal
regulations.
Waste stream Not available
Storage Keep out of reach of children. Store at refrigerated temperatures 36掳 - 46掳 F.
Precautions Read complete package label and insert information before use. Use only as directed. Keep away
from heat. Keep away from sources of ignition. Empty containers pose a fire risk, evaporate the
residue under a fume hood. Ground all equipment containing material. DO NOT breathe dust.
Small spill and leak Absorb with an inert material and place in an appropriate waste disposal container.
Our database contains no additional information in case of a spill and/or a leak of the product. Use a
Large spill and leak
shovel to put the material into a convenient waste disposal container. Finish cleaning by spreading
water on the contaminated surface and allow to evacuate through the sanitary system.
Protective Clothing Gloves, safety glasses
Page 3 of 4
DISAL (FUROSEMIDE) INJECTION NADA #: 131-538




Section 9: Classification
DOT Not a DOT controlled material (United States).


Maritime
Not available
transportation

Not an HCS controlled material in USA.
HCS

Federal and
Not applicable
State
Regulations

HMIS (U.S.A.)
National Fire Protection
Health Hazard 1
Fire Hazard
0
Association (U.S.A.)
Fire Hazard 0
1 0
Reactivity 0
Reactivity
B
Personal Protection
Specific hazard




Section 10: Protective Measures
Protective Gloves. Safety glasses.
clothing

Engineering
Use process enclosures, local exhaust ventilation, or other engineering controls to keep airborne
controls levels below recommended exposure limits. If user operations generate dust, fume or mist, use
ventilation to keep exposure to airborne contaminants below the exposure limit.

Section 11: Other Information
References Not available
Validated by Company: 3/22/05




CALL 1(800) 821-7467
Emergency Medical: (800)530-5432
Chemtrec: (800)424-9300
The information provided herein is offered by Boehringer Ingelheim Vetmedica, Inc. (鈥淏IV鈥?) in good faith as accurate as of the date hereof, but
without guarantee. This information includes information which has been generated by other parties and provided to BIV, and which BIV has
not independently verified. The information provided herein relates only to the specific product designated, and may not be valid where such
product is used in combination with any other materials or in any process. The information provided herein is offered solely for your
consideration, investigation and verification, and Boehringer Ingelheim Vetmedica, Inc. (鈥淏IV鈥?) expressly disclaims all liability for reliance
thereon. BIV EXPRESSLY DISCLAIMS ALL WARRANTIES OF EVERY KIND AND NATURE (INCLUDING WARRANTIES OF
MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE) WITH RESPECT TO THE USE OR SUITABILITY OF THE
PRODUCT. In addition, since the conditions of use and suitability of the product for particular uses are beyond BIV鈥檚 control, ALL RISKS OF
USE OF THE PRODUCT ARE THEREFORE ASSUMED BY THE USER, AND BIV EXPRESSLY
DISCLAIMS ANY AND ALL LIABILITY AS TO ANY RESULTS OBTAINED OR ARISING FROM ANY USE OF THE PRODUCT. Use or
retransmission of the information contained herein in any other format than the format as presented is strictly prohibited. Nothing herein shall
be construed as a permission or recommendation for the use of the product in a manner that might infringe an existing patent. BIV neither
represents nor warrants that the format, content or product formulas contained in this document comply with the laws of any other country
except the United States of America.
漏 Copyright 2001 Boehringer Ingelheim Vetmedica, Inc. All rights reserved.

Page 4 of 4
DISAL (FUROSEMIDE) INJECTION NADA #: 131-538
The information provided herein is offered by Boehringer Ingelheim Vetmedica, Inc. (鈥淏IV鈥?) in
good faith as accurate as of the date hereof, but without guarantee. This information includes
information which has been generated by other parties and provided to BIV, and which BIV has
not independently verified. The information provided herein relates only to the specific product
designated, and may not be valid where such product is used in combination with any other
materials or in any process. The information provided herein is offered solely for your
consideration, investigation and verification, and Boehringer Ingelheim Vetmedica, Inc. (鈥淏IV鈥?)
expressly disclaims all liability for reliance thereon. BIV EXPRESSLY DISCLAIMS ALL
WARRANTIES OF EVERY KIND AND NATURE (INCLUDING WARRANTIES OF
MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE) WITH RESPECT
TO THE USE OR SUITABILITY OF THE PRODUCT. In addition, since the conditions of use
and suitability of the product for particular uses are beyond BIV鈥檚 control, ALL RISKS OF USE
OF THE PRODUCT ARE THEREFORE ASSUMED BY THE USER, AND BIV EXPRESSLY
DISCLAIMS ANY AND ALL LIABILITY AS TO ANY RESULTS OBTAINED OR
ARISING FROM ANY USE OF THE PRODUCT.
Use or re-transmission of the information contained herein in any other format than the format as
presented is strictly prohibited. Nothing herein shall be construed as a permission or
recommendation for the use of the product in a manner that might infringe an existing patent.
BIV neither represents nor warrants that the format, content or product formulas contained in this
document comply with the laws of any other country except the United States of America.
漏 Copyright 2001 Boehringer Ingelheim Vetmedica, Inc. All rights reserved.




Disclaimer.doc

ALL Chemical Analysis PAGES IN THIS GROUP
NAMECAS
94-09-0.asp 94-09-0 25322-68-3 128-44-9
bimsds_us_Acepromazine_Inj_msds.asp N/A
bimsds_us_Aceprom_Maleate_Tab_msds.asp N/A
bimsds_us_Aeropulmin_Syrup_msds.asp N/A
50-00-0.asp 50-00-0 1405-41-0
bimsds_us_Alpha7_MB1_msds.asp N/A
bimsds_us_Alpha7_msds.asp N/A
bimsds_us_AlphaCD_msds.asp N/A
bimsds_us_Alpha_7MB_msds.asp N/A
bimsds_us_AtgardC_SwineWrmer_msds.asp N/A
bimsds_us_Atgard_SwineWrmer_msds.asp N/A
95-48-7.asp 95-48-7 108-39-4 106-44-5
50-00-0.asp 50-00-0 54-64-8
50-00-0.asp 50-00-0 54-64-8
50-00-0.asp 50-00-0
50-00-0.asp 50-00-0
50-00-0.asp 50-00-0
50-00-0.asp 50-00-0
50-00-0.asp 50-00-0
50-00-0.asp 50-00-0
bimsds_us_BioMycin200OxyBivitop_msds.asp N/A
2058-46-0.asp 2058-46-0
67-63-0.asp 67-63-0 100-51-6 548-62-9
95-48-7.asp 95-48-7 108-39-4 106-44-5
10035-04-8.asp 10035-04-8 7778-18-9 10034-76-1
54-64-8.asp 54-64-8 1405-10-3 50-00-0
54-64-8.asp 54-64-8 1405-10-3
54-64-8.asp 54-64-8 1405-10-3
54-64-8.asp 54-64-8 1405-10-3 50-00-0
50-00-0.asp 50-00-0 54-64-8
149-64-4.asp 149-64-4
52645-53-1.asp 52645-53-1 51-03-6
50-00-0.asp 50-00-0
50-00-0.asp 50-00-0
bimsds_us_CalvenzaEHV_msds.asp N/A
bimsds_us_CalvenzaEIVEHV_msds.asp N/A
bimsds_us_CalvenzaEIV_msds.asp N/A
95-48-7.asp 95-48-7 108-39-4 106-44-5
50-00-0.asp 50-00-0
54-64-8.asp 54-64-8
54-64-8.asp 54-64-8
bimsds_us_CitadelVL5_msds.asp N/A
bimsds_us_CSP250_msds.asp N/A
bimsds_us_CSP500_msds.asp N/A
bimsds_us_Denagard10_msds.asp N/A
55297-95-5.asp 55297-95-5 67-17-5
55297-95-5.asp 55297-95-5 67-17-5
bimsds_us_Denagard_Premix_msds.asp N/A
8002-43-5.asp 8002-43-5 50-99-7 7647-14-5 144-55-8 7447-90-7 6132-04-3 127-09-3 56-40-6 7631-86-9 11138-66-2 91-53-2
bimsds_us_Disal_injection_msds.asp N/A


HBCChem,Inc

Chemical Information Net chemcas.orgCopyright Reserved

Trading Lead

Leputech HPLC Laboratory